Sarepta Therapeutics Inc. (AB3A)
Market Closed
4 Jun, 20:00
€
13. 96
-0.06
-0.428%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
-6.99 Eps
€ 14.02
Previous Close Want to track AB3A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.92 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
AB3A Earnings Reports FAQ
What is the earnings per share (EPS) for AB3A?
The current EPS is -6.99.
What is the company's earnings growth rate?
Sarepta Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Sarepta Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Sarepta Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AB3A at this time, as Sarepta Therapeutics Inc has no recent EPS data to calculate it.
